Publications

Found 2 results
Filters: Author is S.R.S. Chalub  [Clear All Filters]
2013
S. R. S. Chalub, da Silva, R. M., da Silva, A. P. S., de Aquino, P. F., Sadahiro, A., and Kalil, A. N., Evaluation of a histocompatibility antigen related to hepatitis B virus in patients with hepatocellular carcinoma in the western Brazilian Amazon, vol. 12, pp. 1336-1346, 2013.
Amarapurpar DN, Patel ND and Kankonkar SR (2003). HLA class II genotyping in chronic hepatitis B infection. J. Assoc. Physicians India 51: 779-781. PMid:14651137   Carrilho FJ, Kikuchi L, Branco F, Gonçalves CS, et al. (2010). Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Clinics 65: 1285-1290. http://dx.doi.org/10.1590/S1807-59322010001200010 PMid:21340216 PMCid:3020338   Chávez J, Campana S and Haas P (2003). Panorama da hepatite B no Brasil e no Estado de Santa Catarina. Rev. Panam Salud Publica 14: 91-96. http://dx.doi.org/10.1590/S1020-49892003000700003 PMid:14577931   Donadi EA (2000). How to understand the nomenclature and the mechanisms involved on the association between histocompatibility antigens and alleles with disease. Medicina Ribeirão Preto 33: 7-18.   Ferreira A, Greca D, Tavares E, Moriya Y, et al. (2006). Soroepidemiologia da hepatite B e C em índios Kaingang do Sul do Brasil. Rev. Panam. Salud Publica 20: 230-235. http://dx.doi.org/10.1590/S1020-49892006000900003 PMid:17316481   Ferreira M (2000). Diagnóstico e tratamento da hepatite B. Rev. Soc. Bras. Med. Trop. 33: 389-400. http://dx.doi.org/10.1590/S0037-86822000000400010 PMid:10936954   Godkin A, Davenport M and Hill AV (2005). Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41: 1383-1390. http://dx.doi.org/10.1002/hep.20716 PMid:15915462   Gustincich S, Manfioletti G, Del SG, Schneider C, et al. (1991). A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 11: 298-300, 302. PMid:1931026   Han YN, Yang JL, Zheng SG, Tang G, et al. (2005). Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients. World J. Gastroenterol. 11 (36): 5721-5724. PMid:16237774   Kummee P, Tangkijvanich Y, Poovorawan P and Hirankarn N (2007). Association of HLA-DRB1*13 and TNF-a gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J. Viral Hepat. 14: 841-848. PMid:18070287   Lee W (1997). Hepatitis B virus infection. New Engl. J. Med. 337: 1733-1745. http://dx.doi.org/10.1056/NEJM199712113372406 PMid:9392700   Lin ZH, Xin YN, Dong QJ, Wang Q, et al. (2010). Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma a meta-analysis. BMC Gastroenterol. 10: 145. http://dx.doi.org/10.1186/1471-230X-10-145 PMid:21172035 PMCid:3016400   Miranda E, Moia L, Amaral I, Barbosa M, et al. (2004). Infecções pelos vírus das hepatites B e C e o carcinoma hepatocelular na Amazônia oriental. Rev. Soc. Bras. Med. Trop. 37: 47-51. PMid:15586896   Olerup O and Zetterquist H (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235. http://dx.doi.org/10.1111/j.1399-0039.1992.tb01940.x PMid:1357775   Ramezani A, Hasanjani-roshan MR, Kalantar E, Eslamifar A, et al. (2008). Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J. Gastroenterol. Hepatol. 23: 1716-1721. http://dx.doi.org/10.1111/j.1440-1746.2008.05482.x PMid:18761557   Romão AMM (2009). Relação Entre a Alpha-Fetoproteína, Doença Hepática Crônica e Carcinoma Hepatocelular, e Estudo Imagiológico Tumoral. Master's thesis, Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã.   Singh R, Kaul R, Kaul A and Khan K (2007). A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J. Gastroenterol. 13: 1770-1787. PMid:17465466   Yang G, Liu J, Han S, Xie H, et al. (2007). Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China. Tissue Antigens 69: 170-175. http://dx.doi.org/10.1111/j.1399-0039.2006.00744.x PMid:17257320   Zhang SY, Gu HX, Li D, Yang SF, et al. (2006). Association of human leukocyte antigen polymorphism with hepatitis B virus infection and genotypes. Jpn. J. Infect. Dis. 59: 353-357. PMid:17186951
2012
P. F. de Aquino, Carvalho, P. C., Fischer, J. Sda Gama, de Souza, A. Q. L., Viana, J. S., Chalub, S. R. S., de Souza, A. D. L., and Carvalho, M. G. C., Epstein-Barr virus DNA associated with gastric adenocarcinoma and adjacent non-cancerous mucosa in patients from Manaus, Brazil, vol. 11, pp. 4442-4446, 2012.
Asaka M, Kimura T, Kato M, Kudo M, et al. (1994). Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73: 2691-2694. http://dx.doi.org/10.1002/1097-0142(19940601)73:11<2691::AID-CNCR2820731107>3.0.CO;2-2   Ebert MP, Niemeyer D, Deininger SO, Wex T, et al. (2006). Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. J. Proteome Res. 5: 2152-2158. http://dx.doi.org/10.1021/pr060011c PMid:16944926   Guerra MR, Gallo CVM, Azevedo G and Mendonça S (2005). Risco de câncer no Brasil: tendências e estudos epidemiológicos mais recentes. Rev. Bras. Cancerol. 51: 227-234.   INCA (2012). Instituto Nacional do Câncer/Estimativa 2012: Incidência de Câncer no Brasil. Available at [http://www.inca.gov.br/estimativa/2012/estimativa20122111.pdf]. Accessed January 20, 2012.   Komoto K, Haruma K, Kamada T, Tanaka S, et al. (1998). Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am. J. Gastroenterol. 93: 1271-1276. http://dx.doi.org/10.1111/j.1572-0241.1998.00408.x PMid:9707050   Lattario F, Furtado YL, Fonseca R, Silveira FA, et al. (2008). Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions. Int. J. Gynecol. Cancer 18: 785-789. http://dx.doi.org/10.1111/j.1525-1438.2007.01060.x PMid:17868341   Lima MAP and Rabenhorst SHB (2006). Association of Epstein-Barr virus (EBV) with solid tumors. Rev. Bras. Cancerol. 52: 87-96.   Lima MAP, Ferreira MVP, Barros MAP, Pardini MIMC, et al. (2011). Epstein-Barr virus (EBV) detection in gastric carcinomas from Ceará and São Paulo states, in Brazil. J. Bras. Patol. Med. Lab. 47: 171-179.   Macsween KF and Crawford DH (2003). Epstein-Barr virus-recent advances. Lancet Infect. Dis. 3: 131-140. http://dx.doi.org/10.1016/S1473-3099(03)00543-7   Mauad EC, Nogueira JL, Souza JMP, Wohnrath DR, et al. (2000). Câncer gástrico em adultos jovens. Rev. Bras. Cancerol. 46: 299-304.   Nishikawa J, Imai S, Oda T, Kojima T, et al. (1999). Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J. Virol. 73: 1286-1292. PMid:9882333 PMCid:103952   Pattle SB and Farrell PJ (2006). The role of Epstein-Barr virus in cancer. Expert Opin. Biol. Ther. 6: 1193-1205. http://dx.doi.org/10.1517/14712598.6.11.1193 PMid:17049016   Pestaner JP, Bibbo M, Bobroski L, Seshamma T, et al. (1994). Potential of the in situ polymerase chain reaction in diagnostic cytology. Acta Cytol. 38: 676-680. PMid:8091896   Rosenbaum V and Riesner D (1987). Temperature-gradient gel electrophoresis. Thermodynamic analysis of nucleic acids and proteins in purified form and in cellular extracts. Biophys. Chem. 26: 235-246. http://dx.doi.org/10.1016/0301-4622(87)80026-1   Saito I, Servenius B, Compton T and Fox RI (1989). Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J. Exp. Med. 169: 2191-2198. http://dx.doi.org/10.1084/jem.169.6.2191 PMid:2543732   Sample JT and Sample CE (2008). Epstein-Barr Virus: Molecular Biology. Encyclopedia of Virology, 3rd edn. Elsevier Ltd., Oxford, 157-167. http://dx.doi.org/10.1016/B978-012374410-4.00392-7   Schulz WA (2005). Molecular Biology of Human Cancers - An Advanced Student's Textbook. Springer, Dordrecht.   Shibata D, Shibata D, Uemura Y, Sato E, et al. (1991). Association of Epstein-Barr virus with undifferentiated gastric carcinoma with intense lymphoid infiltration lymphoepitheliomalike carcinoma. Am. J. Pathol. 139: 469-474. PMid:1653517 PMCid:1886210   Silva AR and Zucoloto SO (2003). The role of Epstein-Barr virus in human tumorigenesis. Medicina 36: 16-23.   Theuer CP, de Virgilio C, Keese G, French S, et al. (1996). Gastric adenocarcinoma in patients 40 years of age or younger. Am. J. Surg. 172: 473-476. http://dx.doi.org/10.1016/S0002-9610(96)00223-1   Tsao SW, Tsang CM, Pang PS, Zhang G, et al. (2012). The biology of EBV infection in human epithelial cells. Seminars Cancer Biol. 22: 137-143. http://dx.doi.org/10.1016/j.semcancer.2012.02.004 PMid:22497025